evodiamine has been researched along with Bladder Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, CY; Ou, HY; Shan, YS; Shieh, GS; Wang, CT; Wu, CL; Wu, HT | 1 |
| Chin, CC; Huang, YC; Kuo, YH; Lee, YR; Li, JM; Shi, CS | 1 |
| He, D; Jin, X; Qu, S; Shi, Q; Zhang, T | 1 |
3 other study(ies) available for evodiamine and Bladder Cancer
| Article | Year |
|---|---|
Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis.
Topics: Animals; Ferroptosis; Glutathione; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipid Peroxides; Phospholipid Hydroperoxide Glutathione Peroxidase; Urinary Bladder Neoplasms | 2023 |
Evodiamine Induces Cell Growth Arrest, Apoptosis and Suppresses Tumorigenesis in Human Urothelial Cell Carcinoma Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinogenesis; Carcinoma; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorescein-5-isothiocyanate; Fluorouracil; Humans; Mutation; Plant Extracts; Quinazolines; Signal Transduction; Urinary Bladder Neoplasms; Urothelium | 2017 |
Evodiamine induces apoptosis and enhances TRAIL-induced apoptosis in human bladder cancer cells through mTOR/S6K1-mediated downregulation of Mcl-1.
Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Down-Regulation; Evodia; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Quinazolines; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Messenger; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms | 2014 |